This study evaluated the rates of dose escalation in patients with Crohn's disease.
Liisa Palmer, PhD
Advertisement
Articles by Liisa Palmer, PhD
This study evaluates the impact of patient cost sharing on the probability of receiving disease-modifying therapies and treatment compliance among patients with multiple sclerosis.
Advertisement
Latest Updated Articles
- Impact of Patient Cost Sharing on Multiple Sclerosis Treatment
Published: November 14th 2012 | Updated:
- Web Exclusive: Real-World Anti-TNF Dose Escalation in Patients With Crohn's Disease
Published: October 27th 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
2
Current and Emerging BCMAxCD3 Bispecifics
3
Same Pathway, Different Profiles: Clinical Considerations for Alpelisib, Capivasertib, and Inavolisib
4
Evolocumab Reduces Risk of Major Events in Patients Without Prior Cardiovascular History
5
